The general view on biostimulants is that they are neither fertilizers nor pesticides, and are in some ways beneficial to the plant body. Given the urgent need to enhance the productivity of agricultural lands, this niche segment has been registering robust growth. Regional bodies, such as the European Biostimulant Industry Council (EBIC) and Biostimulant Coalition, have defined the segment to provide a clear picture.

The synthetic biology market was valued at USD 22.47 billion, in 2018. The market is expected to register a growth rate of 34.91% over the forecast period. The primary drivers for the market include increasing support from government and private institutions and increasing R&D investments in drug discovery and development. Based on the product, the market was dominated by the enabled product in 2018. The fastest growing subsegment over the forecast period, under the product segmentation, was estimated to be enabled products. The enabled product sub-segment is expected to register a CAGR of 35.19% over the forecast period.

The increasing environmental awareness and growing threats to the ecology have been forcing government bodies and regulatory agencies around the world to develop newer practices, in order to create sustainable human communities. As a part of the same, there have been many developments lately to enhance the recyclability of resources, such as wastewater sludge and excreta (the primary sources of biosolids), as they are dangerous to both the human health and the environment, if not managed properly. The pollution prevention programs and industrial pretreatment in the United States have substantially reduced levels of metals and other pollutants going into wastewater treatment plants, resulting in noticeable improvements in biosolids’ quality. The capital expenditure and management of municipal wastewater treatment services has been increasing in the recent times in the United States. The Public Owned Treatment Works (POTW) in the United States produces nearly 0.16 pounds (by dry weight) of sewage sludge per person per day, among the total sewage treatment services.

Currently, the healthcare industry in Nigeria is hindered by the lack of funds from the Nigerian government, often resulting in insufficient supply of medical equipment, administrative bottlenecks, and limited licensed medical laboratory professionals. The public healthcare expenditures are really less accounting for only about 5%, and private (out of pocket) expenditure to about 75%. This statistic is drastically different from several developed and emerging markets.

The advent of new technologies, with stringent environment norms, increasing health safety measures have changed the entire industry viewpoint, with respect to the compliance of standards and regulations. Testing, inspection, and certification (TIC) plays a significant role to ensure the infrastructure, services, products are met with the standards and regulations pertaining to safety and quality. With inspection and testing at regular intervals across a few industries, such as oil and gas becoming mandatory, the TIC services are expected to grow in demand, irrespective of the industrial seasonality.

The integration of robotics and automation in labs is rapidly increasing, owing to the enhanced productivity and mitigated operational cost for laboratories. This is likely to boost the market growth during the forecast period. The progress in research and discovery of the organs, including the polymerase chain reaction (PCR), splice genes, means of sequencing, are on a rise, which may propel the market growth.

The adoption of single-use technology has proven to be a robust, scalable, and reliable form of sources from lab-scale to cGMP production applications, such as flexible contaminant, single-use bioprocessing equipment, and single-use filtration assemblies. Hence, the use of single-use technologies in virus filtration helps to marginally reduce the risk of cross-contamination, increasing the safety profile of the manufacturing process.